Chronology of age-related disease definitions: Osteoporosis and sarcopenia

Ageing Research Reviews

Volumn 11, Issue 2, 2012, Pages 320-324

  Bijlsma, A Y ^a   Meskers, C G M ^a   Westendorp, R G J ^a   Maier, A B ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ageing; Consensus; Definition; History; Osteoporosis; Sarcopenia

Indexed keywords

AWARENESS; BONE DENSITY; CHRONOLOGY; COGNITION; CONSENSUS; FUNCTIONAL DISEASE; HUMAN; MEDLINE; MORTALITY; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE STRENGTH; OSTEOPOROSIS; REVIEW; WORLD HEALTH ORGANIZATION; X RAY FILM;

AGE FACTORS; AGING; BONE AND BONES; BONE DENSITY; CONSENSUS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MUSCLE STRENGTH; MUSCLE, SKELETAL; ORGAN SIZE; OSTEOPOROSIS; SARCOPENIA; TERMINOLOGY AS TOPIC;

EID: 84857025841     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2012.01.001     Document Type: Review

References (45)

1. Abellan van K.G. Epidemiology and consequences of sarcopenia. J. Nutr. Health Aging 2009, 13:708-712.
2. Adams R.D., Harrison T.R. Principles of Internal Medicine 1962, McGraw-Hill, New York. 4th ed.
3. Albright F. Annals of internal medicine. Nutr. Rev. 1989, 47:85-86.
4. Albright F. Annals of internal medicine. Osteoporosis 1947, 27:85-86.
5. Albright F., Smith P.H., Richardson A.M. Postmenopausal osteoporosis. JAMA 1941, 116:2465-2474.
6. Baumgartner R.N., Koehler K.M., Gallagher D., Romero L., Heymsfield S.B., Ross R.R., Garry P.J., Lindeman R.D. Epidemiology of sarcopenia among the elderly in New Mexico. Am. J. Epidemiol. 1998, 147:755-763.
7. Baumgartner R.N., Waters D.L., Gallagher D., Morley J.E., Garry P.J. Predictors of skeletal muscle mass in elderly men and women. Mech. Ageing Dev. 1999, 107:123-136.
8. Bijlsma, A.Y., Meskers, C.G., Ling, C.H., Narici, M., Kurrle, S.E., Cameron, I.D., Westendorp, R.G., Maier, A.B. Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a middle aged cohort. AGE, doi:10.1007/s11357-012-9384-z.
9. Blake G.M., Fogelman I. An update on dual-energy X-ray absorptiometry. Semin. Nucl. Med. 2010, 40:62-73.
10. Buford T.W., Anton S.D., Judge A.R., Marzetti E., Wohlgemuth S.E., Carter C.S., Leeuwenburgh C., Pahor M., Manini T.M. Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Res. Rev. 2010, 9:369-383.
11. Bunout D., de la Maza M.P., Barrera G., Leiva L., Hirsch S. Association between sarcopenia and mortality in healthy older people. Australas. J. Ageing 2011, 30:89-92.
12. Burns J.M., Johnson D.K., Watts A., Swerdlow R.H., Brooks W.M. Reduced lean mass in early Alzheimer disease and its association with brain atrophy. Arch. Neurol. 2010, 67:428-433.
13. Clark B.C., Manini T.M. Sarcopenia ≠ dynapenia. J. Gerontol. A Biol. Sci. Med. Sci. 2008, 63:829-834.
14. Conference report (no authors listed), 1991. Consensus development conference: prophylaxis and treatment of osteoporosis. Am. J. Med. 90, 107-110.
15. Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., Boirie, Y., Cederholm, T., Landi, F., Martin, F.C., Michel, J.P., Rolland, Y., Schneider, S.M., Topinkova, E., Vandewoude, M., Zamboni, M., 2010. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing.
16. Delmonico M.J., Harris T.B., Lee J.S., Visser M., Nevitt M., Kritchevsky S.B., Tylavsky F.A., Newman A.B. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J. Am. Geriatr. Soc. 2007, 55:769-774.
17. Delmonico M.J., Harris T.B., Visser M., Park S.W., Conroy M.B., Velasquez-Mieyer P., Boudreau R., Manini T.M., Nevitt M., Newman A.B., Goodpaster B.H. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am. J. Clin. Nutr. 2009, 90:1579-1585.
18. Englesbe M.J., Patel S.P., He K., Lynch R.J., Schaubel D.E., Harbaugh C., Holcombe S.A., Wang S.C., Segev D.L., Sonnenday C.J. Sarcopenia and mortality after liver transplantation. J. Am. Coll. Surg. 2010, 211:271-278.
19. Fielding R.A., Vellas B., Evans W.J., Bhasin S., Morley J.E., Newman A.B., Abellan van K.G., Andrieu S., Bauer J., Breuille D., Cederholm T., Chandler J., De M.C., Donini L., Harris T., Kannt A., Keime G.F., Onder G., Papanicolaou D., Rolland Y., Rooks D., Sieber C., Souhami E., Verlaan S., Zamboni M. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology and consequences. J. Am. Med. Dir. Assoc. 2011, 12:249-256. International working group on sarcopenia.
20. Fujiwara S., Nakamura T., Orimo H., Hosoi T., Gorai I., Oden A., Johansson H., Kanis J.A. Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos. Int. 2008, 19:429-435.
21. Goodpaster B.H., Park S.W., Harris T.B., Kritchevsky S.B., Nevitt M., Schwartz A.V., Simonsick E.M., Tylavsky F.A., Visser M., Newman A.B. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61:1059-1064.
22. Harrison T.R. Principles of Internal Medicine 1958, McGraw-Hill, New York. 3rd ed.
23. Harrison T.R., Beeson W.H., Resnik W.H., Thorn G.W., Wintrobe M.M. Principles of Internal Medicine 1950, Blakiston Company, Philadelphia. 1st ed.
24. Harrison T.R., Wintrobe M.M. Principles of Internal Medicine 1970, McGraw-Hill, New York. 6th ed.
25. Janssen I., Baumgartner R.N., Ross R., Rosenberg I.H., Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am. J. Epidemiol. 2004, 159:413-421.
26. Janssen I., Heymsfield S.B., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J. Am. Geriatr. Soc. 2002, 50:889-896.
27. Janssen I., Shepard D.S., Katzmarzyk P.T., Roubenoff R. The healthcare costs of sarcopenia in the United States. J. Am. Geriatr. Soc. 2004, 52:80-85.
28. Kanis J.A., Johnell O., Oden A., Johansson H., McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos. Int. 2008, 19:385-397.
29. Kanis J.A., McCloskey E.V., Johansson H., Oden A., Melton L.J., Khaltaev N. A reference standard for the description of osteoporosis. Bone 2008, 42:467-475.
30. Koenigsberg R. Churchill's Illustrated Medical Dictionary 1989, Churchill Livingstone, New York.
31. Lauretani F., Russo C.R., Bandinelli S., Bartali B., Cavazzini C., Di I.A., Corsi A.M., Rantanen T., Guralnik J.M., Ferrucci L. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J. Appl. Physiol. 2003, 95:1851-1860.
32. Melton L.J., Wahner H.W. Defining osteoporosis. Calcif. Tissue Int. 1989, 45:263-264.
33. Muscaritoli M., Anker S.D., Argiles J., Aversa Z., Bauer J.M., Biolo G., Boirie Y., Bosaeus I., Cederholm T., Costelli P., Fearon K.C., Laviano A., Maggio M., Rossi F.F., Schneider S.M., Schols A., Sieber C.C. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) cachexia-anorexia in chronic wasting diseases and " nutrition in geriatrics" Clin. Nutr. 2010, 29:154-159.
34. Newman A.B., Kupelian V., Visser M., Simonsick E., Goodpaster B., Nevitt M., Kritchevsky S.B., Tylavsky F.A., Rubin S.M., Harris T.B. Sarcopenia: alternative definitions and associations with lower extremity function. J. Am. Geriatr. Soc. 2003, 51:1602-1609.
35. Newman A.B., Kupelian V., Visser M., Simonsick E.M., Goodpaster B.H., Kritchevsky S.B., Tylavsky F.A., Rubin S.M., Harris T.B. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61:72-77.
36. Nordin B.E. The definition and diagnosis of osteoporosis 1987. Salud Publica Mex. 2009, 51(Suppl. 1):S132-S133.
37. Prado C.M., Baracos V.E., McCargar L.J., Reiman T., Mourtzakis M., Tonkin K., Mackey J.R., Koski S., Pituskin E., Sawyer M.B. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin. Cancer Res. 2009, 15:2920-2926.
38. Reifenstein E.C., Albright F. The metabolic effects of steroid hormones in osteoporosis. J. Clin. Invest. 1947, 26:24-56.
39. Rosenberg I.H. Sarcopenia: origins and clinical relevance. J. Nutr. 1997, 127:990S-991S.
40. Schapira D., Schapira C. Osteoporosis: the evolution of a scientific term. Osteoporos. Int. 1992, 2:164-167.
41. Visser M. Towards a definition of sarcopenia-results from epidemiologic studies. J. Nutr. Health Aging 2009, 13:713-716.
42. Walker M.D., Babbar R., Opotowsky A.R., Rohira A., Nabizadeh F., Badia M.D., Chung W., Chiang J., Mediratta A., McMahon D., Liu G., Bilezikian J.P. A referent bone mineral density database for Chinese American women. Osteoporos. Int. 2006, 17:878-887.
43. Watkins E.S. The Estrogen Elixir: A History of Hormone Replacement Therapy in America Baltimore 2007, Johns Hopkins University Press, Baltimore, America.
44. World Health Organization, 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. report of a WHO study group. WHO Technical Report Series, 843 ed. Geneva: World Health Organization.
45. Wylie C.D. Setting a standard for a silent disease: defining osteoporosis in the 1980 and 1990. Stud. Hist. Philos. Biol. Biomed. Sci. 2010, 41:376-385.